Albin Björk

Publications
CV
Public outreach and news

Selected publications

Review: NATURE REVIEWS RHEUMATOLOGY. 2023;19(5):288-306
Genetics and epigenetics of primary Sjogren syndrome: implications for future therapies
Thorlacius GE; Bjork A; Wahren-Herlenius M

Articles

Article: RHEUMATOLOGY. 2025;64(9):5096-5100
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study
Barguil Macedo M; Wahadat MJ; Bjork A; Kamphuis S; Versnel MA; Lood C
Article: ANNALS OF THE RHEUMATIC DISEASES. 2025;84(9):1512-1527
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland
Wiley MM; Radziszewski M; Khatri B; Joachims ML; Tessneer KL; Stolarczyk AM; Yao S; Li J; Pritchett-Frazee C; Johnston AA; Rasmussen A; Anaya J-M; Aqrawi LA; Bae S-C; Baecklund E; Bjork A; Brun JG; Bucher SM; Dand N; Eloranta M-L; Engelke F; Forsblad-d'Elia H; Fugmann C; Glenn SB; Gong C; Gottenberg J-E; Hammenfors D; Imgenberg-Kreuz J; Jensen JL; Johnsen SJA; Jonsson MV; Kelly JA; Khanam S; Kim K; Kvarnstrom M; Mandl T; Martin J; Morris DL; Nocturne G; Norheim KB; Olsson P; Palm O; Pers J-O; Rhodus NL; Sjowall C; Skarstein K; Taylor KE; Tombleson P; Thorlacius GE; Venuturupalli SR; Vital EM; Wallace DJ; Radfar L; Brennan MT; James JA; Scofield RH; Gaffney PM; Criswell LA; Jonsson R; Appel S; Eriksson P; Bowman SJ; Omdal R; Ronnblom L; Warner BM; Rischmueller M; Witte T; Farris AD; Mariette X; Shiboski CH; Wahren-Herlenius M; Alarcon-Riquelme ME; Ng W-F; Sivils KL; Guthridge JM; Adrianto I; Vyse TJ; Tsao BP; Nordmark G; Lessard CJ
Article: RHEUMATOLOGY. 2025;64(7):4341-4346
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's disease
Fugmann C; Reid S; Pucholt P; Kvarnstrom M; Bjork A; Mofors J; Sjowall C; Eriksson P; Olsson P; Mandl T; Forsblad-d'Elia H; Magnusson Bucher S; Johnsen SJ; Norheim KB; Appel S; Hammenfors D; Jensen JL; Palm O; Omdal R; Jonsson R; Baecklund E; Wahren-Herlenius M; Leonard D; Imgenberg-Kreuz J; Nordmark G
Article: JOURNAL OF AUTOIMMUNITY. 2025;154:103434
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides
Shibahara T; Temizoz B; Egashira S; Hosomi K; Park J; Surucu N; Bjork A; Sag E; Doi T; Ekinci RMK; Balci S; Versnel MA; Kunisawa J; Yamamoto M; Hayashi T; Ito S; Kamiyama Y; Kobiyama K; Katsikis PD; Coban C; Gursel M; Ozen S; Nishida S; Kumanogoh A; Ishii KJ
Article: RMD OPEN. 2025;11(2):e005351
Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
Bjork A; Wahadat MJ; Sanchez-Blazquez M; Braams M; Rip J; van Tilburg SJ; van Helden-Meeuwsen CG; Kamphuis S; van den Bosch TPP; Brkic Z; Versnel MA
Article: ARTHRITIS RESEARCH & THERAPY. 2025;27(1):49
Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation
Juto A; Martin M; Bjork A; Padyukov L; Gronwall C; Antovic A; Bruchfeld A; Gunnarsson I; Blom AM
Article: RHEUMATOLOGY. 2021;60(3):1445-1455
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment
Bjork A; Rodrigues RDS; Andersson ER; Sepulveda JIR; Mofors J; Kvarnstrom M; Oke V; Svenungsson E; Gunnarsson I; Wahren-Herlenius M
Article: RHEUMATOLOGY. 2021;60(2):837-848
Genetic and clinical basis for two distinct subtypes of primary Sjogren's syndrome
Thorlacius GE; Hultin-Rosenberg L; Sandling JK; Bianchi M; Imgenberg-Kreuz J; Pucholt P; Theander E; Kvarnstrom M; Forsblad-d'Elia H; Bucher SM; Norheim KB; Johnsen SJA; Hammenfors D; Skarstein K; Jonsson MV; Baecklund E; Aqrawi LA; Jensen JL; Palm O; Morris AP; Meadows JRS; Rantapaa-Dahlqvist S; Mandl T; Eriksson P; Lind L; Omdal R; Jonsson R; Lindblad-Toh K; Ronnblom L; Wahren-Herlenius M; Nordmark G
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:580547
Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection
Palsson SA; Dondalska A; Bergenstrahle J; Rolfes C; Bjork A; Sedano L; Power UF; Rameix-Welti M-A; Lundeberg J; Wahren-Herlenius M; Mastrangelo P; Eleouet J-F; Le Goffic R; Galloux M; Spetz A-L
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:582737
Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
Martin M; Trattner R; Nilsson SC; Bjork A; Zickert A; Blom AM; Gunnarsson I
Article: RMD OPEN. 2020;6(3):e001402
Cigarette smoking patterns preceding primary Sjogren's syndrome
Mofors J; Bjork A; Richardsdotter Andersson E; Kvarnstrom M; Forsblad D'Elia H; Magnusson-Bucher S; Padyukov L; Kockum I; Hillert J; Eriksson P; Mandl T; Nordmark G; Alfredsson L; Wahren-Herlenius M
Article: RHEUMATOLOGY. 2020;59(7):1651-1661
Viral antigens elicit augmented immune responses in primary Sjogren's syndrome
Bjork A; Thorlacius GE; Mofors J; Andersson ER; Ivanchenko M; Tingstrom J; James T; Brokstad KA; Cox RJ; Jonsson R; Kvarnstrom M; Wahren-Herlenius M
Article: RMD OPEN. 2020;6(1):e000995
Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjogren's syndrome
Bjork A; Andersson ER; Imgenberg-Kreuz J; Thorlacius GE; Mofors J; Syvanen A-C; Kvarnstrom M; Nordmark G; Wahren-Herlenius M
Article: BIOLOGY OF SEX DIFFERENCES. 2019;10(1):60
Sex differences in clinical presentation of systemic lupus erythematosus
Sepulveda JIR; Bolin K; Mofors J; Leonard D; Svenungsson E; Jonsen A; Bengtsson C; Nordmark G; Dahlqvist SR; Bengtsson AA; Ronnblom L; Sjowall C; Gunnarsson I; Wahren-Herlenius M; Zickert A; Bjork A; Jonsen A; Sjowali C; Enocsson H; Wettero J; Eriksson P; Thorlacius GE; Lundberg IE; Sanding JK; SeNiveda JIR; Lindblad-Toh K; Ronnblom L; Padyukov L; Hultin-Rosenberg L; Eloranta M-L; Dahiqvist SR
Article: JOURNAL OF INTERNAL MEDICINE. 2019;286(4):458-468
Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjogren's syndrome
Mofors J; Holmqvist M; Westermark L; Bjork A; Kvarnstrom M; Forsblad-d'Elia H; Bucher SM; Eriksson P; Theander E; Mandl T; Wahren-Herlenius M; Nordmark G
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(6):670-680
Infections increase the risk of developing Sjogren's syndrome
Mofors J; Arkema EV; Bjork A; Westermark L; Kvarnstrom M; Forsblad-d'Elia H; Bucher SM; Eriksson P; Mandl T; Nordmark G; Wahren-Herlenius M
Article: ELIFE. 2019;8:e41608
In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta
Pernemalm M; Sandberg A; Zhu Y; Boekel J; Tamburro D; Schwenk JM; Bjork A; Wahren-Herlenius M; Amark H; Ostenson C-G; Westgren M; Lehtio J
Article: FRONTIERS IN IMMUNOLOGY. 2018;9:1939
Early Resistance of Non-virulent Mycobacterial Infection in C57BL/6 Mice Is Associated With Rapid Up-Regulation of Antimicrobial Cathelicidin Camp
Adam L; Lopez-Gonzalez M; Bjork A; Palsson S; Poux C; Wahren-Herlenius M; Fernandez C; Spetz A-L
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2018;192(3):259-270
Diminished CXCR5 expression in peripheral blood of patients with Sjogren's syndrome may relate to both genotype and salivary gland homing
Aqrawi LA; Ivanchenko M; Bjork A; Sepulveda JIR; Imgenberg-Kreuz J; Kvarnstrom M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2018;87(5):e12662
Transcription profiling of peripheral B cells in antibody-positive primary Sjogren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature
Imgenberg-Kreuz J; Sandling JK; Bjork A; Nordlund J; Kvarnstrom M; Eloranta M-L; Ronnblom L; Wahren-Herlenius M; Syvanen A-C; Nordmark G
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):266
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.
Martin M; Smoląg KI; Björk A; Gullstrand B; Okrój M; Leffler J; Jönsen A; Bengtsson AA; Blom AM
Article: CELL DEATH AND DIFFERENTIATION. 2016;23(5):903-911
Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes.
Martin M; Leffler J; Smoląg KI; Mytych J; Björk A; Chaves LD; Alexander JJ; Quigg RJ; Blom AM
Show more

All other publications

Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2024;83:42-43
OP0179 DISEASE ASSOCIATED AUTOANTIBODIES ARE LINKED TO GRADUAL PROTEOMIC CHANGES IN PRIMARY SJÖGREN’S SYNDROME
Björk A; Mofors J; Meneghel L; Kvarnström M; Jonsson R; Omdal R; Forsblad-D’elia H; Bucher SM; Eriksson P; Mandl T; Olsson P; Imgenberg-Kreuz J; Nordmark G; Wahren-Herlenius M
Preprint: BIORXIV. 2023;BIORXIV
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Wiley MM; Khatri B; Joachims ML; Tessneer KL; Stolarczyk AM; Rasmussen A; Anaya J-M; Aqrawi LA; Bae S-C; Baecklund E; Björk A; Brun JG; Bucher SM; Dand N; Eloranta M-L; Engelke F; Forsblad-d'Elia H; Fugmann C; Glenn SB; Gong C; Gottenberg J-E; Hammenfors D; Imgenberg-Kreuz J; Jensen JL; Johnsen SJA; Jonsson MV; Kelly JA; Khanam S; Kim K; Kvarnström M; Mandl T; Martín J; Morris DL; Nocturne G; Norheim KB; Olsson P; Palm Ø; Pers J-O; Rhodus NL; Sjöwall C; Skarstein K; Taylor KE; Tombleson P; Thorlacius GE; Venuturupalli S; Vital EM; Wallace DJ; Grundahl KM; Radfar L; Brennan MT; James JA; Scofield RH; Gaffney PM; Criswell LA; Jonsson R; Appel S; Eriksson P; Bowman SJ; Omdal R; Rönnblom L; Warner BM; Rischmueller M; Witte T; Farris AD; Mariette X; Shiboski CH; Sjögren’s International Collaborative Clinical All; Wahren-Herlenius M; Alarcón-Riquelme ME; PRECISESADS Clinical Consortium; Ng W-F; UK Primary Sjögren’s Syndrome Registry; Sivils KL; Guthridge JM; Adrianto I; Vyse TJ; Tsao BP; Nordmark G; Lessard CJ
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:705
SEX-EQTL ANALYSIS REVEALS A SIGNIFICANT SEXBIAS IN THE EFFECTS OF SJOGREN'S SYNDROME ASSOCIATED ALLELES ON GENE TRANSCRIPTION
Thorlacius GE; Bjork A; Wahren-Herlenius M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1068
AMLEXANOX INHIBITS PRODUCTION OF TYPE I INTERFERON AND SUPPRESSES B CELL DIFFERENTIATION AND IMMUNOGLOBULIN PRODUCTION IN VITRO: A POTENTIAL NOVEL THERAPEUTIC OPTION FOR SLE
Bjork A; Wahadat MJ; Braams M; Van Helden-Meeuwsen CG; Versnel M
Review: RHEUMATOLOGY. 2021;60(6):2561-2573
Innate immunity and interferons in the pathogenesis of Sjogren's syndrome
Bodewes ILA; Bjork A; Versnel MA; Wahren-Herlenius M
Book chapter: OXFORD TEXTBOOK OF SJÖGREN'S SYNDROME. 2021;p. 33-44
Autoantibodies and autoantigens in Sjögren’s syndrome
Ambrosi A; Björk A; Wahren-Herlenius M
Doctoral thesis: 2021
Immunopathogenic mechanisms in primary Sjögren’s syndrome
Björk A
Corrigendum: RHEUMATOLOGY. 2021;60(3):1575
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment (vol 60, pg 1445, 2021)
Bjork A; Rodrigues RDS; Andersson ER; Sepulveda JIR; Mofors J; Kvarnstrom M; Oke V; Svenungsson E; Gunnarsson I; Wahren-Herlenius M
Review: JOURNAL OF INTERNAL MEDICINE. 2020;287(5):475-492
Environmental factors in the pathogenesis of primary Sjogren's syndrome
Bjork A; Mofors J; Wahren-Herlenius M
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):307-308
Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
Mofors J; Bjoerk A; Smedby KE; Kvarnstrom M; Forsblad-d'Elia H; Magnusson-Bucher S; Eriksson P; Mandl T; Baecklund E; Nordmark G; Wahren-Herlenius M
Conference publication: MOLECULAR IMMUNOLOGY. 2019;114:416-417
PLASMA C4d CORRELATES WITH C4d DEPOSITION IN KIDNEYS AND WITH TREATMENT RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS
Martin M; Nilsson SC; Bjork A; Gunnarsson I; Blom AM
Letter: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2019;195(3):305-309
FoxP3⁺CXCR5⁺CD4⁺ T cell frequencies are increased in peripheral blood of patients with primary Sjogren's syndrome
Ivanchenko M; Aqrawi LA; Bjork A; Wahren-Herlenius M; Chemin K
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(12):1840-1842
Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjogren's syndrome
Aqrawi LA; Mentlein L; Meneghel L; Bjork A; Thorlacius GE; Ivanchenko M; Sepulveda JIR; Skarstein K; Kvarnstrom M; Brauner S; Espinosa A; Wahren-Herlenius M
Meeting abstract: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018;36(3):S330
Cigarette smoking is a risk factor for developing primary Sjogren's syndrome with Ro/SSA and La/SSB autoantibodies
Bjork A; Mofors J; Kvarnstrom M; Forsblad-d'Elia H; Bucher SM; Hillert J; Eriksson P; Mandl T; Nordmark G; Alfredsson L; Wahren-Herlenius M
Meeting abstract: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018;36(3):S331-S332
Primary Sjogren's syndrome increases the risk of cardiovascular events, with the highest risk in SSA/SSB autoantibody positive patients
Mofors J; Westermark L; Bjork A; Kvarnstrom M; Forsblad-d'Elia H; Bucher SM; Eriksson P; Mandl T; Wahren-Herlenius M; Nordmark G
Meeting abstract: ARTHRITIS & RHEUMATOLOGY. 2016;68
Expression of the Chemokine Receptor CXCR5 Is Decreased in the Periphery of Patients with Primary Sjogren's Syndrome
Wahren-Herlenius M; Aqrawi LA; Ivanchenko M; Bjork A; Ramirez J; Kvarnstrom M; Jensen JCL; Skarstein K

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2024-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2021

Selected publications

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI